Edition:
India

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

17.57USD
20 Mar 2019
Change (% chg)

$1.92 (+12.27%)
Prev Close
$15.65
Open
$17.06
Day's High
$18.01
Day's Low
$16.91
Volume
2,971
Avg. Vol
1,846
52-wk High
$18.90
52-wk Low
$11.30

Blom, Mats 

Mr. Mats Peter Blom no longer serves as Executive Vice President, Chief Financial Officer and Member of the Executive Management at Zealand Pharma A/S effective as of end of March 2019 (March 31, 2019). He has held the position since 2017. He has previously been Senior Vice President, Chief Financial Officer and Member of the Executive Management since January 3, 2011. Before that, he has been Vice President and CFO of the Company since March 1, 2010. He served as CFO at Swedish Orphan International. He has managerial experience and has held CFO positions at Active Biotech and Anoto both publicly listed on Nasdaq Stockholm. Previously, Mats worked for several years as a management consultant at Gemini Consulting and at Ernst & Young’s Transaction Services division. He holds a BA in Business Administration and Economics from the University of Lund followed by an MBA from IESE University of Navarra, Barcelona. Mats is Chairman of the Board for Medical Need AB and Board Member of Auris Medical AG.

Basic Compensation

Total Annual Compensation, DKK 6,405,000
Restricted Stock Award, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK --
Fiscal Year Total, DKK 6,405,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --